Fineline Cube

Follow:
14499 Articles
rand Pharma's GPN01768 Approved in Macau for Demodectic Blepharitis
CompanyDrug

Grand Pharma’s GPN01768 Approved in Macau for Demodectic Blepharitis

Medtronic's Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications
CompanyMedical Device

Medtronic’s Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications

Tonghua Dongbao to Sell Stake in Amoytop Biotech for USD 181 Million
CompanyDeals

Tonghua Dongbao to Sell Stake in Amoytop Biotech for USD 181 Million

Shandong Boan Biotechnology Partners with HKUST for Biomedicine Innovation
CompanyDeals

Shandong Boan Biotechnology Partners with HKUST for Biomedicine Innovation

PacBio Appoints Haorui Gene as Official Distributor in China
CompanyDeals

PacBio Appoints Haorui Gene as Official Distributor in China

Zhongsheng Pharma's Anruiwei Receives NMPA Approval for Influenza A
CompanyDrug

Zhongsheng Pharma’s Anruiwei Receives NMPA Approval for Influenza A

CARsgen's Satri-Cel Shows Significant Efficacy in Gastric Cancer Study
CompanyDrug

CARsgen’s Satri-Cel Shows Significant Efficacy in Gastric Cancer Study

Viz.ai Partners with Sanofi and Regeneron to Deploy AI Solution for COPD
CompanyDeals

Viz.ai Partners with Sanofi and Regeneron to Deploy AI Solution for COPD

GSK's Nucala Receives FDA Approval for COPD Treatment
CompanyDrug

GSK’s Nucala Receives FDA Approval for COPD Treatment

Merck's Welireg Launched in China for Rare Genetic Disorder Treatment
CompanyDrug

Merck’s Welireg Launched in China for Rare Genetic Disorder Treatment

NMPA Approves Bayer/Regeneron's Eylea HD for Wet AMD Treatment
CompanyDrug

NMPA Approves Bayer/Regeneron’s Eylea HD for Wet AMD Treatment

Ascentage Pharma to Present Data on Lisaftoclax and Alrizomadlin at ASCO 2025
CompanyDrug

Ascentage Pharma to Present Data on Lisaftoclax and Alrizomadlin at ASCO 2025